Genor Biopharma Holdings Ltd
Genor Biopharma Holdings's GHG Emissions Data Preview
In 2023, Genor Biopharma Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Genor Biopharma Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Genor Biopharma Holdings's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Genor Biopharma Holdings amounted to 2,487.16 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Genor Biopharma Holdings decreased by 59.83%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Genor Biopharma Holdings's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Genor Biopharma Holdings's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Genor Biopharma Holdings were 19.82 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Genor Biopharma Holdings reduced its Scope 1 emissions over time?
Since 2021, Genor Biopharma Holdings's Scope 1 emissions have decreased by 3.36%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Genor Biopharma Holdings's Scope 1 emissions increased by 10.42%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Genor Biopharma Holdings's Scope 2 emissions?
In 2023, Genor Biopharma Holdings reported Scope 2 greenhouse gas (GHG) emissions of 2,467.34 tCOâ‚‚e without specifying the calculation method.
Has Genor Biopharma Holdings reduced its Scope 2 emissions over time?
Since 2021, Genor Biopharma Holdings's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 68.88%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Genor Biopharma Holdings's Scope 2 emissions (Unspecified Calculation Method) fell by 60.03% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Genor Biopharma Holdings use for Scope 2 reporting?
In 2023, Genor Biopharma Holdings reported its Scope 2 emissions using an unspecified methodology.
Genor Biopharma Holdings's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Genor Biopharma Holdings's Total Carbon Footprint
In 2023, Genor Biopharma Holdings reported a total carbon footprint of 2,487.16 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 59.83% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Genor Biopharma Holdings's total carbon footprint was Scope 2 emissions, accounting for 99.2% of the company's total carbon footprint, followed by Scope 1 emissions at 0.8%.